tiprankstipranks
GlaxoSmithKline (GB:GSK)
LSE:GSK
Holding GB:GSK?
Track your performance easily

GlaxoSmithKline (GSK) Ownership - Who Owns GlaxoSmithKline?

710 Followers

GlaxoSmithKline (GSK) Ownership Overview

1.08%11.07%0.08%11.01%76.77%
0.08% Other Institutional Investors
11.01% ETFs
76.77% Public Companies and
Individual Investors
The ownership structure of GlaxoSmithKline (GB:GSK) stock is a mix of institutional, retail, and individual investors. Approximately 22.16% of the company’s stock is owned by Institutional Investors, 1.08% is owned by Insiders, and 76.77% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 30, 2024
Jonathan Symonds
Chairman,director
xxxxxxxxxxxxx
£99646
Jun 22, 2024
Hal Barron
Chief Science Officer,director
xxxxxxxxxxxxx
$9131
Jun 22, 2024
Jonathan Symonds
Chairman,director
xxxxxxxxxxxxx
£32291
Jun 22, 2024
Vishal Sikka
Non Executive,director
xxxxxxxxxxxxx
$48062

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
180,821,050Institution4.36%3,210,839,385
139,929,683Institution3.38%2,484,731,381
84,599,540Institution2.04%1,502,234,032
55,633,153Institution1.34%987,877,898
42,099,269Insider1.02%747,556,720
36,708,771Institution0.89%651,837,647
34,809,358Institution0.84%618,109,770
33,677,084Institution0.81%598,003,981
28,866,867Institution0.70%512,588,957
23,647,902Institution0.57%419,915,796

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
84,599,540Institution2.04%1,502,234,032
55,633,153Institution1.34%987,877,898
36,708,771Institution0.89%651,837,647
33,677,084Institution0.81%598,003,981
28,866,867Institution0.70%512,588,957
23,647,902Institution0.57%419,915,796
18,606,977Institution0.45%330,404,091
14,353,401Institution0.35%254,873,342
13,347,147Institution0.32%237,005,289
13,105,309Institution0.32%232,710,972

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
55,785,220Institution1.35%1,007,401,610
34,428,891Institution0.83%621,736,741
26,009,536Institution0.63%428,209,912
13,695,061Institution0.33%225,469,646
8,014,964Institution0.19%144,738,836
7,957,798Institution0.19%143,706,499
9,809,440Institution0.24%136,596,452
7,924,663Institution0.19%130,346,778
7,677,043Institution0.19%126,391,563
5,390,962Institution0.13%88,754,500

FAQ

Who Owns GlaxoSmithKline (GB:GSK)?
According to the latest TipRanks data, approximately 0.08% of the company's stock is held by institutional investors, 1.08% is held by insiders, and 76.77% is held by retail investors.
    What percentage of GlaxoSmithKline (GB:GSK) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.08% of GlaxoSmithKline (GB:GSK) stock is held by institutional investors.
      What percentage of GlaxoSmithKline (GB:GSK) stock is held by retail investors?
      According to the latest TipRanks data, approximately 76.77% of GlaxoSmithKline (GB:GSK) stock is held by retail investors.
        Who owns the most shares of GlaxoSmithKline (GB:GSK)?
        iShares owns the most shares of GlaxoSmithKline (GB:GSK).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis